<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05009667</url>
  </required_header>
  <id_info>
    <org_study_id>FlashIII</org_study_id>
    <nct_id>NCT05009667</nct_id>
  </id_info>
  <brief_title>Diagnostic Value of Coronary Angiography-Derived Index of Microvascular Resistance in INOCA Patients (FlashIII)</brief_title>
  <acronym>FlashIII</acronym>
  <official_title>A Prospective, Multi-center Clinical Trial to Evaluate the Effectiveness and Safety of Coronary Angiography-Derived Index of Microvascular Resistance Measured Online by a Coronary Functional Measurement System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ge Junbo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>RainMed Medical</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fudan University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      More than 50% of patients with stable or unstable angina pectoris have no obstructive&#xD;
      coronary arteries by angiographic visual estimation, in which coronary microvascular&#xD;
      dysfunction (CMD) is one of the causes of myocardial ischemia and chest pain. A coronary&#xD;
      angiography-derived index of microvascular resistance (caIMR) is proposed for physiological&#xD;
      assessment of microvascular diseases in coronary circulation. The aim of the trial is to&#xD;
      assess diagnostic performance of caIMR in INOCA patients, using wire-derived index of&#xD;
      microvascular resistance (IMR) as the reference standard.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      More than 50% of patients with stable or unstable angina pectoris have no obstructive&#xD;
      coronary arteries by angiographic visual estimation, in which coronary microvascular&#xD;
      dysfunction (CMD) is one of the causes of myocardial ischemia and chest pain. Presently, the&#xD;
      index of microvascular resistance (IMR) measured by the pressure wire is recognized as&#xD;
      standard for evaluating coronary microcirculatory function. A coronary angiography-derived&#xD;
      index of microvascular resistance (caIMR) is proposed for physiological assessment of&#xD;
      microvascular diseases in coronary circulation without pressure wire, hyperemic agents, or&#xD;
      thermodilution method.&#xD;
&#xD;
      This study is a prospective, multi-center clinical trial. In the study, IMR (measured by&#xD;
      pressure wire) will be used as a reference standard to evaluate the feasibility, accuracy and&#xD;
      safety of caIMR measured by a non-invasive diagnosis system (FM21a) based on angiography&#xD;
      images and aortic pressure wave. 116 INOCA patients will be enrolled in the study. Both IMR&#xD;
      and caIMR measurement will be performed in the same patient in a random order after&#xD;
      angiography. The definitions of IMR and caIMR for coronary microcirculatory ischemia are&#xD;
      IMR≥25 and caIMR≥25. The primary endpoint is the diagnostic accuracy of caIMR. The secondary&#xD;
      endpoint is caIMR's sensitivity, specificity, positive predictive value, negative predictive&#xD;
      value, ROC curve and AUC of caIMR diagnosis, and the diagnostic characteristics of caIMR at&#xD;
      the vascular level.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 14, 2021</start_date>
  <completion_date type="Anticipated">March 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic accuracy</measure>
    <time_frame>Through study completion, an average of 7 months.</time_frame>
    <description>To compare diagnostic accuracy of caIMR for coronary microcirculatory lesions with IMR as control.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sensitivity, specificity, positive predictive value, and negative predictive value</measure>
    <time_frame>Through study completion, an average of 7 months.</time_frame>
    <description>To compare the diagnostic performance between caIMR and IMR in the patient level, with IMR as the reference standard.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ROC curve, and AUC</measure>
    <time_frame>Through study completion, an average of 7 months.</time_frame>
    <description>Using IMR as reference standard, draw the ROC curve of caIMR. The definition of ischemia is IMR≥25.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diagnostic performance on the vessel level</measure>
    <time_frame>Through study completion, an average of 7 months.</time_frame>
    <description>The diagnostic features of caIMR compared with IMR on the vessel level.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">116</enrollment>
  <condition>Coronary Microvascular Dysfunction</condition>
  <arm_group>
    <arm_group_label>IMR first group</arm_group_label>
    <description>In this group, IMR based on pressure wire and arterial physiological detector will be measured first, and then caIMR base on angiography images and pressure sensor will be measured secondly.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>caIMR first group</arm_group_label>
    <description>In this group, caIMR based on angiography images and pressure sensor will be measured first, and then IMR based on pressure wire and arterial physiological detector will be measured secondly.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Angiography-derived Index of Microcirculatory Resistance</intervention_name>
    <description>caIMR will be measured by pressure sensors which are produced by Suzhou Rainmed Medical Technology Co., Ltd.&#xD;
caIMR is calculated based on angiography images and Hyperemic Pa estimated from resting Pa according to prespecified equation.</description>
    <arm_group_label>IMR first group</arm_group_label>
    <arm_group_label>caIMR first group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pressure wire-based Index of Microcirculatory Resistance</intervention_name>
    <description>IMR will be measured by thermodilution method with pressure wire and arterial physiological detector which are produced by St. Jude Medical.&#xD;
IMR = Pd ∙Tmn</description>
    <arm_group_label>IMR first group</arm_group_label>
    <arm_group_label>caIMR first group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with stable or unstable angina, or suspected myocardial ischemia.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients aged 18 years and above, 80 years old and below, with no gender limitation;&#xD;
&#xD;
          2. Patients with stable or unstable angina or suspected myocardial ischemia;&#xD;
&#xD;
          3. Patients voluntarily participated in this clinical trial and signed an informed&#xD;
             consent form;&#xD;
&#xD;
          4. Visually the lumen diameter stenosis of any major epicardial coronary&lt;50%.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with suspected acute myocardial infarction;&#xD;
&#xD;
          2. Patients with old myocardial infarction;&#xD;
&#xD;
          3. Patients with primary or secondary cardiomyopathy;&#xD;
&#xD;
          4. Patients with primary or secondary heart valve disease;&#xD;
&#xD;
          5. Patients with severe cardiac insufficiency and LVEF≤35%;&#xD;
&#xD;
          6. Patients with renal insufficiency (eGFR&lt;60ml/min (1.73)) or patients undergoing&#xD;
             dialysis;&#xD;
&#xD;
          7. Patients who are allergic to iodine contrast agents, adenosine, and ATP;&#xD;
&#xD;
          8. Patients with severe organ disease or life expectancy less than 24 months;&#xD;
&#xD;
          9. Patients who are participating in other clinical studies of investigational drugs or&#xD;
             devices and have not reached their primary endpoint;&#xD;
&#xD;
         10. The patient who has other conditions that are not suitable for clinical trials;&#xD;
&#xD;
         11. Patients with coronary artery involved in coronary fistula and myocardial bridge;&#xD;
&#xD;
         12. The contrast media is not filled, the blood vessels are overlapped, or the target&#xD;
             blood vessel is severely distorted, and the lesion location cannot be fully exposed,&#xD;
             or the image quality is poor and cannot be recognized;&#xD;
&#xD;
         13. Left main coronary artery disease and right coronary artery orifice disease;&#xD;
&#xD;
         14. After angiography, the investigator believes that the patient cannot tolerate any of&#xD;
             the detection methods between caIMR and IMR;&#xD;
&#xD;
         15. The investigator believes that the patient is not suitable for clinical trials after&#xD;
             angiography;&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Junbo Ge, PHD</last_name>
    <role>Study Director</role>
    <affiliation>Fudan University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dong Huang, MD</last_name>
    <phone>13512142875</phone>
    <email>huang.dong@zs-hospital.sh.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Linli Tang</last_name>
    <phone>15250056047</phone>
    <email>tanglinli@rainmed.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zhongshan Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dong Huang</last_name>
      <phone>13512142875</phone>
      <email>huang.dong@zs-hospital.sh.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Li J, Gong Y, Wang W, Yang Q, Liu B, Lu Y, Xu Y, Huo Y, Yi T, Liu J, Li Y, Xu S, Zhao L, Ali ZA, Huo Y. Accuracy of computational pressure-fluid dynamics applied to coronary angiography to derive fractional flow reserve: FLASH FFR. Cardiovasc Res. 2020 Jun 1;116(7):1349-1356. doi: 10.1093/cvr/cvz289.</citation>
    <PMID>31693092</PMID>
  </reference>
  <reference>
    <citation>Fearon WF, Balsam LB, Farouque HM, Caffarelli AD, Robbins RC, Fitzgerald PJ, Yock PG, Yeung AC. Novel index for invasively assessing the coronary microcirculation. Circulation. 2003 Jul 1;107(25):3129-32. Epub 2003 Jun 23. Erratum in: Circulation. 2003 Dec 23;108(25):3165.</citation>
    <PMID>12821539</PMID>
  </reference>
  <reference>
    <citation>Ford TJ, Berry C. How to Diagnose and Manage Angina Without Obstructive Coronary Artery Disease: Lessons from the British Heart Foundation CorMicA Trial. Interv Cardiol. 2019 May 21;14(2):76-82. doi: 10.15420/icr.2019.04.R1. eCollection 2019 May. Review.</citation>
    <PMID>31178933</PMID>
  </reference>
  <reference>
    <citation>Kunadian V, Chieffo A, Camici PG, Berry C, Escaned J, Maas AHEM, Prescott E, Karam N, Appelman Y, Fraccaro C, Louise Buchanan G, Manzo-Silberman S, Al-Lamee R, Regar E, Lansky A, Abbott JD, Badimon L, Duncker DJ, Mehran R, Capodanno D, Baumbach A. An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology &amp; Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. Eur Heart J. 2020 Oct 1;41(37):3504-3520. doi: 10.1093/eurheartj/ehaa503.</citation>
    <PMID>32626906</PMID>
  </reference>
  <reference>
    <citation>Fearon WF, Farouque HM, Balsam LB, Caffarelli AD, Cooke DT, Robbins RC, Fitzgerald PJ, Yeung AC, Yock PG. Comparison of coronary thermodilution and Doppler velocity for assessing coronary flow reserve. Circulation. 2003 Nov 4;108(18):2198-200. Epub 2003 Oct 20. Erratum in: Circulation. 2003 Dec 23;108(25):3165.</citation>
    <PMID>14568891</PMID>
  </reference>
  <reference>
    <citation>Ai H, Feng Y, Gong Y, Zheng B, Jin Q, Zhang HP, Sun F, Li J, Chen Y, Huo Y, Huo Y. Coronary Angiography-Derived Index of Microvascular Resistance. Front Physiol. 2020 Dec 16;11:605356. doi: 10.3389/fphys.2020.605356. eCollection 2020.</citation>
    <PMID>33391020</PMID>
  </reference>
  <reference>
    <citation>Aarnoudse W, Fearon WF, Manoharan G, Geven M, van de Vosse F, Rutten M, De Bruyne B, Pijls NH. Epicardial stenosis severity does not affect minimal microcirculatory resistance. Circulation. 2004 Oct 12;110(15):2137-42. Epub 2004 Oct 4.</citation>
    <PMID>15466646</PMID>
  </reference>
  <reference>
    <citation>Kobayashi Y, Lee JM, Fearon WF, Lee JH, Nishi T, Choi DH, Zimmermann FM, Jung JH, Lee HJ, Doh JH, Nam CW, Shin ES, Koo BK. Three-Vessel Assessment of Coronary Microvascular Dysfunction in Patients With Clinical Suspicion of Ischemia: Prospective Observational Study With the Index of Microcirculatory Resistance. Circ Cardiovasc Interv. 2017 Nov;10(11). pii: e005445. doi: 10.1161/CIRCINTERVENTIONS.117.005445.</citation>
    <PMID>29146670</PMID>
  </reference>
  <reference>
    <citation>Yoon MH, Tahk SJ, Yang HM, Woo SI, Lim HS, Kang SJ, Choi BJ, Choi SY, Hwang GS, Shin JH. Comparison of accuracy in the prediction of left ventricular wall motion changes between invasively assessed microvascular integrity indexes and fluorine-18 fluorodeoxyglucose positron emission tomography in patients with ST-elevation myocardial infarction. Am J Cardiol. 2008 Jul 15;102(2):129-34. doi: 10.1016/j.amjcard.2008.03.024. Epub 2008 May 29.</citation>
    <PMID>18602508</PMID>
  </reference>
  <reference>
    <citation>Williams RP, de Waard GA, De Silva K, Lumley M, Asrress K, Arri S, Ellis H, Mir A, Clapp B, Chiribiri A, Plein S, Teunissen PF, Hollander MR, Marber M, Redwood S, van Royen N, Perera D. Doppler Versus Thermodilution-Derived Coronary Microvascular Resistance to Predict Coronary Microvascular Dysfunction in Patients With Acute Myocardial Infarction or Stable Angina Pectoris. Am J Cardiol. 2018 Jan 1;121(1):1-8. doi: 10.1016/j.amjcard.2017.09.012. Epub 2017 Oct 10.</citation>
    <PMID>29132649</PMID>
  </reference>
  <reference>
    <citation>De Maria GL, Alkhalil M, Wolfrum M, Fahrni G, Borlotti A, Gaughran L, Dawkins S, Langrish JP, Lucking AJ, Choudhury RP, Porto I, Crea F, Dall'Armellina E, Channon KM, Kharbanda RK, Banning AP. Index of Microcirculatory Resistance as a Tool to Characterize Microvascular Obstruction and to Predict Infarct Size Regression in Patients With STEMI Undergoing Primary PCI. JACC Cardiovasc Imaging. 2019 May;12(5):837-848. doi: 10.1016/j.jcmg.2018.02.018. Epub 2018 Apr 18.</citation>
    <PMID>29680355</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>July 23, 2021</study_first_submitted>
  <study_first_submitted_qc>August 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 17, 2021</study_first_posted>
  <last_update_submitted>October 28, 2021</last_update_submitted>
  <last_update_submitted_qc>October 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Fudan University</investigator_affiliation>
    <investigator_full_name>Ge Junbo</investigator_full_name>
    <investigator_title>Coordinating Investigator</investigator_title>
  </responsible_party>
  <keyword>Hemodynamics</keyword>
  <keyword>Computational fluid dynamics</keyword>
  <keyword>INOCA</keyword>
  <keyword>Index of microcirculatory resistance</keyword>
  <keyword>Fractional flow reserve</keyword>
  <keyword>Angiography-derived IMR</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

